Elevance Health, Inc. $ELV Holdings Lifted by High Ground Investment Management LLP

Key Points

• High Ground Investment Management increased its stake in Elevance by 12.7% to 326,081 shares (≈$114.3M), making ELV about 16.6% of the fund's holdings; institutional investors own roughly 89.24% of the company.
• Analyst sentiment is mixed with a MarketBeat consensus rating of "Hold" and a consensus target price of $385.38, while individual firms have varied targets (e.g., Mizuho $350, Wolfe $425, JPMorgan $397).
• Elevance beat quarterly EPS estimates ($3.33 vs. $3.10), reported revenue up 9.6% year-over-year, and raised its quarterly dividend to $1.72 (annualized $6.88, yield ~2.2%, payout ratio ~27.4%).

High Ground Investment Management LLP boosted its position in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) by 12.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 326,081 shares of the company's stock after buying an additional 36,849 shares during the quarter. Elevance Health makes up about 16.6% of High Ground Investment Management LLP's holdings, making the stock its 4th biggest holding. High Ground Investment Management LLP owned about 0.15% of Elevance Health worth $114,308,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in ELV. Physician Wealth Advisors Inc. boosted its position in Elevance Health by 331.6% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 82 shares of the company's stock valued at $26,000 after buying an additional 63 shares during the period. Activest Wealth Management boosted its position in Elevance Health by 66.7% during the 3rd quarter. Activest Wealth Management now owns 85 shares of the company's stock valued at $27,000 after buying an additional 34 shares during the period. Rossby Financial LCC boosted its position in Elevance Health by 110.0% during the 3rd quarter. Rossby Financial LCC now owns 84 shares of the company's stock valued at $28,000 after buying an additional 44 shares during the period. Motco boosted its position in Elevance Health by 334.8% during the 3rd quarter. Motco now owns 100 shares of the company's stock valued at $32,000 after buying an additional 77 shares during the period. Finally, True Wealth Design LLC boosted its position in Elevance Health by 431.8% during the 3rd quarter. True Wealth Design LLC now owns 117 shares of the company's stock valued at $38,000 after buying an additional 95 shares during the period. Hedge funds and other institutional investors own 89.24% of the company's stock.

Analysts Set New Price Targets

ELV has been the subject of several analyst reports. Mizuho dropped their price target on shares of Elevance Health from $413.00 to $350.00 and set an "outperform" rating for the company in a research report on Wednesday, March 11th. Wolfe Research set a $425.00 price target on shares of Elevance Health and gave the company an "outperform" rating in a research report on Thursday, January 8th. JPMorgan Chase & Co. increased their price target on shares of Elevance Health from $394.00 to $397.00 and gave the company an "overweight" rating in a research report on Monday, February 2nd. Wall Street Zen downgraded shares of Elevance Health from a "buy" rating to a "hold" rating in a research report on Sunday, February 8th. Finally, Morgan Stanley decreased their price objective on shares of Elevance Health from $359.00 to $352.00 and set an "equal weight" rating for the company in a report on Wednesday, December 17th. Twelve research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $385.38.

Elevance Health Stock Up 0.0%

Shares of NYSE ELV opened at $311.54 on Monday. The company has a current ratio of 1.54, a quick ratio of 1.54 and a debt-to-equity ratio of 0.70. Elevance Health, Inc. has a 12 month low of $273.71 and a 12 month high of $443.29. The firm has a market capitalization of $68.43 billion, a PE ratio of 12.40, a price-to-earnings-growth ratio of 1.71 and a beta of 0.49. The firm has a fifty day simple moving average of $311.25 and a two-hundred day simple moving average of $332.13.

Elevance Health (NYSE:ELV - Get Free Report) last issued its quarterly earnings data on Wednesday, January 28th. The company reported $3.33 EPS for the quarter, topping the consensus estimate of $3.10 by $0.23. Elevance Health had a net margin of 2.84% and a return on equity of 15.59%. The business had revenue of $49.31 billion during the quarter, compared to analyst estimates of $49.52 billion. During the same period in the prior year, the business earned $3.84 EPS. The company's revenue for the quarter was up 9.6% on a year-over-year basis. Elevance Health has set its FY 2026 guidance at 25.500- EPS. Equities analysts expect that Elevance Health, Inc. will post 33.96 earnings per share for the current year.

Elevance Health Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 25th. Stockholders of record on Tuesday, March 10th were given a $1.72 dividend. The ex-dividend date of this dividend was Tuesday, March 10th. This represents a $6.88 dividend on an annualized basis and a dividend yield of 2.2%. This is a boost from Elevance Health's previous quarterly dividend of $1.71. Elevance Health's payout ratio is currently 27.39%.

About Elevance Health

Elevance Health, Inc NYSE: ELV is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company's strategic focus on integrated health care and benefit delivery.

Elevance's core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.